Frontiers in nephrologyPub Date : 2026-07-13eCollection Date: 2026-01-01DOI: 10.3389/fneph.2026.1809424
Mariel Hernández-Pérez, Daniel Enos, Rocío Contreras Faundez, Joaquín Ramírez Herrera, Pablo Tapia Riedemann, Gonzalo P Méndez, Jorge Gutiérrez Ventura
{"title":"Case Report: Renal sarcoidosis coexisting with membranous and IgA nephropathy, a very uncommon association.","authors":"Mariel Hernández-Pérez, Daniel Enos, Rocío Contreras Faundez, Joaquín Ramírez Herrera, Pablo Tapia Riedemann, Gonzalo P Méndez, Jorge Gutiérrez Ventura","doi":"10.3389/fneph.2026.1809424","DOIUrl":"10.3389/fneph.2026.1809424","url":null,"abstract":"<p><strong>Introduction: </strong>Sarcoidosis is a multisystemic inflammatory disease of unknown etiology with more frequent lung and lymph node involvement. Despite kidney involvement occurring between 25% and 43%, it may be underdiagnosed, with interstitial granulomatous nephritis and nephrocalcinosis being the most common features, and glomerular disease being less frequent.</p><p><strong>Case report: </strong>A 43-year-old man came to the emergency room (ER) because of macroscopic hematuria, arthralgias, pitting inferior extremities edema, asthenia, and dry cough without dyspnea. Evaluation revealed nephrotic range proteinuria and glomerular hematuria, suggesting an impure nephrotic syndrome. The kidney biopsy showed features of membranous nephropathy and granulomatous interstitial nephritis, with immunofluorescence showing codominant mesangial immunoglobulin A (IgA) and immunoglobulin G (IgG) deposits.</p><p><strong>Management and outcome: </strong>Steroids plus angiotensin receptor blocker (ARB) antagonists were effective, with symptoms subsiding and proteinuria level decreasing after 8 months of follow-up.</p>","PeriodicalId":73091,"journal":{"name":"Frontiers in nephrology","volume":"6 ","pages":"1809424"},"PeriodicalIF":2.9,"publicationDate":"2026-07-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13402197/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148610717","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Frontiers in nephrologyPub Date : 2026-07-07eCollection Date: 2026-01-01DOI: 10.3389/fneph.2026.1921166
Abdulrashid Hashi Mohamed, Mohamud Mire Waberi, Feyza Aksu, Nurto Abdulkadir Said, Said Abdirahman Ahmed
{"title":"Correction: Intradialytic blood pressure instability and associated factors among hemodialysis patients in Somalia: a retrospective study.","authors":"Abdulrashid Hashi Mohamed, Mohamud Mire Waberi, Feyza Aksu, Nurto Abdulkadir Said, Said Abdirahman Ahmed","doi":"10.3389/fneph.2026.1921166","DOIUrl":"https://doi.org/10.3389/fneph.2026.1921166","url":null,"abstract":"<p><p>[This corrects the article DOI: 10.3389/fneph.2026.1822440.].</p>","PeriodicalId":73091,"journal":{"name":"Frontiers in nephrology","volume":"6 ","pages":"1921166"},"PeriodicalIF":2.9,"publicationDate":"2026-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13386396/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148551649","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Frontiers in nephrologyPub Date : 2026-06-29eCollection Date: 2026-01-01DOI: 10.3389/fneph.2026.1862772
Li Jiang, Tingting Li, Haojun Zhang, Xiai Wu, Tingting Zhao
{"title":"Plasma proteomics based on machine learning predict the early risk of kidney outcomes in patients with DKD: a prospective cohort study from UK Biobank.","authors":"Li Jiang, Tingting Li, Haojun Zhang, Xiai Wu, Tingting Zhao","doi":"10.3389/fneph.2026.1862772","DOIUrl":"10.3389/fneph.2026.1862772","url":null,"abstract":"<p><strong>Background: </strong>Diabetic kidney disease (DKD) is the predominant cause of end-stage kidney disease worldwide. Early identification of patients at heightened risk for adverse kidney outcomes remains a critical unmet clinical need.</p><p><strong>Methods: </strong>We conducted a prospective cohort study of 918 DKD participants from the UK Biobank. Baseline plasma proteomic profiling quantified 1,463 proteins using Olink proximity extension assays. Three nested Cox proportional hazards models with incremental covariate adjustment identified proteins associated with composite kidney outcomes. To prevent information leakage, all feature selection, hyperparameter optimization, and model development were performed exclusively within the training cohort (70% random split) via a multi-stage pipeline integrating LASSO-Cox regression, Random Survival Forest, Boruta algorithm, and Sequential Forward Selection. XGBoost Cox modeling with SHAP interpretability analysis quantified variable contributions. Predictive performance was validated through Kaplan-Meier survival analysis, 15-year longitudinal trajectory modeling, ROC benchmarking, 10-fold nested cross-validation, and sensitivity analyses restricted to KDIGO-defined DKD. An interactive web application was developed for clinical translation.</p><p><strong>Results: </strong>Of 1,463 proteins examined, 633 demonstrated significant associations with kidney outcomes across all three Cox models. Functional enrichment highlighted immune-inflammatory pathways, PI3K-Akt signaling, and chemokine cascades as central to DKD progression. The machine learning framework identified an 11-protein signature, which was refined to 10 core biomarkers (HLA-E, EFNA1, GPR158, FSTL3, ART3, GM2A, CLEC1A, CKAP4, IFNGR1, EPHA2) following survival and longitudinal trajectory validation. The protein-only model achieved robust discrimination (AUC = 0.808 [95% CI 0.767-0.848] for composite outcomes; AUC = 0.807 [95% CI 0.765-0.848] for renal death), comparable to fully integrated models incorporating demographics and metabolic variables. Systematic benchmarking across 101 algorithm combinations identified LASSO-RSF as optimal (C-index = 0.94 in training; 0.73 in independent testing), with reliable calibration through mid-term follow-up (Integrated Calibration Index = 0.019-0.022). The web-based tool enables real-time, personalized risk stratification.</p><p><strong>Conclusions: </strong>This study establishes a validated 10-protein signature for early prediction of kidney outcomes in DKD. The systematic machine learning framework and deployable web application provide accessible, interpretable risk assessment to support precision nephrology and preemptive clinical intervention.</p>","PeriodicalId":73091,"journal":{"name":"Frontiers in nephrology","volume":"6 ","pages":"1862772"},"PeriodicalIF":2.9,"publicationDate":"2026-06-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13357851/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148439102","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Frontiers in nephrologyPub Date : 2026-06-26eCollection Date: 2026-01-01DOI: 10.3389/fneph.2026.1781576
Jessica Forsyth, David Randall, Raj Thuraisingham
{"title":"Accuracy of valganciclovir dosing following kidney transplantation and its impact on clinical outcomes.","authors":"Jessica Forsyth, David Randall, Raj Thuraisingham","doi":"10.3389/fneph.2026.1781576","DOIUrl":"10.3389/fneph.2026.1781576","url":null,"abstract":"<p><p>Valganciclovir is widely used as prophylaxis against cytomegalovirus (CMV) infection following solid organ transplantation. However, valganciclovir requires dose adjustment based on kidney function. This retrospective observational study at a London kidney transplant center explored the accuracy of valganciclovir dosing in the first 3 months following transplantation and its impact on clinical outcomes. Data for adult kidney transplant recipients (KTRs) receiving valgancivloir prophylaxis between 2017 to 2019 was analyzed. The primary outcome was the difference between the prescribed and optimum valganciclovir dose (calculated by creatinine clearance) on days 10-92 after surgery. Secondary outcomes included associations between valganciclovir dosing with CMV DNAemia, cytopenias and rejection. For the 90 KTRs included, the valganciclovir dose was optimum for 51%, underdosed for 31% and overdosed for 18% of the study period. Significant associations were shown for underdosing and CMV DNAemia (B = 2.88, SE = 1.14, p=0.01, 95% CI [1.90,166.1]) as well as overdosing and neutropenia (B = 2.29, SE 0.99, p=0.02, 95% CI [1.42,68.71]). This study highlights the difficulty in optimally dosing valganciclovir in KTRs post-operatively and importantly shows significant associations between suboptimal dosing and clinical outcomes.</p>","PeriodicalId":73091,"journal":{"name":"Frontiers in nephrology","volume":"6 ","pages":"1781576"},"PeriodicalIF":2.9,"publicationDate":"2026-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13350519/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148426934","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"No association between delayed graft function and BK polyomavirus infection reactivation after kidney transplantation: a systematic review and meta-analysis.","authors":"Thidarat Kitrungphaiboon, Felicity Evison, Suzy Gallier, Adnan Sharif","doi":"10.3389/fneph.2026.1790723","DOIUrl":"10.3389/fneph.2026.1790723","url":null,"abstract":"<p><strong>Introduction: </strong>An association between delayed graft function (DGF) and BK polyomavirus (BKPyV) DNAemia is not well defined.</p><p><strong>Methods: </strong>We investigated this with 1) a retrospective review of a single-center cohort analysis, and 2) a systematic review & meta-analysis of published data. Kidney transplant recipients at a single-center between 01/01/2007-30/06/2018 were analyzed. Comparative analyses were done with logistic regression models based upon clinical risk factors. Following a systematic review of published studies, meta-analysis was performed using the DerSimonian-Laird random effects model.</p><p><strong>Results: </strong>In our single-center analysis, we analyzed 1,770 kidney transplant recipients with median follow up 5.3 years (interquartile range 2.7-8.7 years). BKPyVDNAemia was associated with; male sex (8.3% versus 5.3% respectively, p=0.017), ABO-incompatible transplantation (10.3% versus 4.6% respectively, p=0.004) and DGF (9.0% versus 6.3% respectively, p=0.048). In a multivariate analysis, only recipient male sex and ABO-incompatible transplantation was associated with BKPyVDNAemia. In a systematic review of published literature, we identified 11 studies and performed a meta-analysis of empirical data including our Birmingham cohort data. No significant association was observed between DGF rates and BKPyVDNAemia (OR 1.00, 95% CI 0.67-1.50).</p><p><strong>Discussion: </strong>We did not identify any association between DGF rates and subsequent BKPyVDNAemia.</p>","PeriodicalId":73091,"journal":{"name":"Frontiers in nephrology","volume":"6 ","pages":"1790723"},"PeriodicalIF":2.9,"publicationDate":"2026-06-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13337812/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148407215","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Frontiers in nephrologyPub Date : 2026-06-23eCollection Date: 2026-01-01DOI: 10.3389/fneph.2026.1822440
Abdulrashid Hashi Mohamed, Mohamud Mire Waberi, Feyza Aksu, Nurto Abdulkadir Said, Said Abdirahman Ahmed
{"title":"Intradialytic blood pressure instability and associated factors among hemodialysis patients in Somalia: a retrospective study.","authors":"Abdulrashid Hashi Mohamed, Mohamud Mire Waberi, Feyza Aksu, Nurto Abdulkadir Said, Said Abdirahman Ahmed","doi":"10.3389/fneph.2026.1822440","DOIUrl":"10.3389/fneph.2026.1822440","url":null,"abstract":"<p><strong>Background: </strong>Intradialytic blood pressure (BP) instability-manifesting as intradialytic hypotension (IDH) or hypertension (IDHT)-is increasingly recognized as a contributor to cardiovascular morbidity in hemodialysis patients. Despite its clinical significance, data on intradialytic BP behavior from sub-Saharan Africa remain scarce.</p><p><strong>Objective: </strong>To determine the prevalence and clinical factors associated with intradialytic BP changes among chronic kidney disease (CKD) patients on maintenance hemodialysis in a tertiary hospital in Somalia.</p><p><strong>Methods: </strong>We conducted a retrospective observational study of adult patients undergoing maintenance hemodialysis at Mogadishu Somali Turkish Training and Research Hospital between June and September 2022. Intradialytic hypotension was defined as a ≥20 mmHg drop in systolic BP and/or ≥10 mmHg drop in mean arterial pressure (MAP), while IDHT was defined as a >10 mmHg increase in systolic BP and/or ≥15 mmHg increase in MAP from pre- to post-dialysis. Demographic, clinical, dialysis, and laboratory variables were extracted. Logistic regression models were used to evaluate factors associated with IDH and IDHT, with reduced modeling for IDHT because of the small number of events.</p><p><strong>Results: </strong>Among 149 patients (mean age 51.1 ± 16.4 years; 57.7% female), the prevalence of IDH and IDHT was 55.0% and 12.1%, respectively. Most patients (74.5%) had hypertension and 96.5% used an arteriovenous fistula. In multivariable analysis, higher pre-dialysis systolic BP (OR 1.037; 95% CI 1.018-1.056) and ultrafiltration goal (OR 1.537; 95% CI 1.002-2.357) were associated with IDH. Because pre-dialysis systolic BP contributed to the outcome definition, this association should be interpreted cautiously. In the reduced IDHT model, ultrafiltration goal was inversely associated with IDHT (OR 0.543; 95% CI 0.298-0.990), while antihypertensive medication burden was not statistically significant. Exploratory electrolyte tertile analysis showed a higher proportion of IDH among patients in lower calcium and higher phosphate tertiles.</p><p><strong>Conclusion: </strong>Intradialytic BP instability was common among hemodialysis patients in Somalia, particularly IDH. Given the retrospective design, reliance on pre- and post-dialysis BP measurements, and limited number of IDHT events, the findings should be interpreted as associative and hypothesis-generating. Routine BP monitoring and further prospective studies are warranted to better characterize hemodynamic instability in resource-constrained dialysis settings.</p>","PeriodicalId":73091,"journal":{"name":"Frontiers in nephrology","volume":"6 ","pages":"1822440"},"PeriodicalIF":2.9,"publicationDate":"2026-06-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13337759/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148407266","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Correction: Successful reintegration of a very elderly patient with rapidly progressive glomerulonephritis due to microscopic polyangiitis after multidisciplinary treatment: a case report.","authors":"Tatsuo Tsukamoto, Yui Fukuda, Kaoru Ohue, Atsuto Niwa, Sanae Ogura, Takuya Ishimura, Takaya Handa, Tomomi Endo, Takeshi Matsubara","doi":"10.3389/fneph.2026.1895403","DOIUrl":"https://doi.org/10.3389/fneph.2026.1895403","url":null,"abstract":"<p><p>[This corrects the article DOI: 10.3389/fneph.2026.1803876.].</p>","PeriodicalId":73091,"journal":{"name":"Frontiers in nephrology","volume":"6 ","pages":"1895403"},"PeriodicalIF":2.9,"publicationDate":"2026-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13329341/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148392653","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Frontiers in nephrologyPub Date : 2026-06-11eCollection Date: 2026-01-01DOI: 10.3389/fneph.2026.1773762
Nguyen Thi Thuy, Le Viet Thang
{"title":"Plasma asymmetric dimethylarginine and its association with cardiovascular risk factors in Vietnamese patients before and after kidney transplantation, 2018-2022.","authors":"Nguyen Thi Thuy, Le Viet Thang","doi":"10.3389/fneph.2026.1773762","DOIUrl":"10.3389/fneph.2026.1773762","url":null,"abstract":"<p><strong>Background: </strong>Asymmetric dimethylarginine (ADMA) levels in patients with chronic kidney disease (CKD) are associated with cardiovascular events and mortality following kidney transplantation (KT). Therefore, ADMA may serve as a risk factor for cardiovascular complications in kidney transplant recipients. This study aimed to evaluate plasma ADMA concentrations and their association with cardiovascular risk factors in Vietnamese patients with end-stage renal disease (ESRD) before and after KT.</p><p><strong>Methods: </strong>From January 2018 to December 2022, 75 patients with ESRD who underwent KT were clinically evaluated using Doppler ultrasound, laboratory tests, and ADMA quantification both before and 6 months after KT. Additionally, 80 healthy people were selected as a control group. ADMA levels before and after KT were statistically analyzed to identify associations with cardiovascular risk factors.</p><p><strong>Results: </strong>The findings indicate that 100% of patients with ESRD before KT exhibited elevated levels of urea, creatinine, proteinuria, a long with a decreased glomerular filtration rate (GFR)< 60 ml/min. After KT, these abnormalities decreased to 17.3%, 41.3%, 5.3%, and 9.3%, respectively. Clinical indices such as hypertension, elevated CRP, anemia, left ventricular hypertrophy, and EF%< 50% were observed after KT at rates of 29.3%, 21.3%, 61.4%, and 34.7%, respectively. However, dyslipidemia and AIP > 0.11 increased by 2.6% and 10.7%, respectively, after KT compared to before. The average ADMA concentrations of patients before KT, after KT, and in healthy controls were 0.62 µmol/L, 0.57 µmol/L vs 0.17 µmol/L, respectively. Before KT, 93.3% of patients exhibited elevated ADMA levels, which decreased to 32.0% after KT. Males presented higher ADMA levels than females both before and after KT, as well as in healthy controls. ADMA levels showed minimal variation across different age groups. Before KT, dyslipidemia (cholesterol), AIP (> 0.11), and LA diameter were associated with increased ADMA levels. Lower hemoglobin and lower HDL-C levels at 6 months post-transplant were independently associated with an increased risk of ADMA elevation from pre-transplant to 6 months post-transplant.</p><p><strong>Conclusion: </strong>ADMA levels in patients with end-stage renal disease were 3.65 times higher than those in healthy controls. Although ADMA levels decreased after KT, they remained elevated compared to healthy controls. Hemoglobin and LDL-C were independent factors associated with changes in ADMA concentration between the pre-transplant and six-month post-transplant periods.</p>","PeriodicalId":73091,"journal":{"name":"Frontiers in nephrology","volume":"6 ","pages":"1773762"},"PeriodicalIF":2.9,"publicationDate":"2026-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13294190/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148347296","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Frontiers in nephrologyPub Date : 2026-06-10eCollection Date: 2026-01-01DOI: 10.3389/fneph.2026.1738155
Ashraf Hassan Abd El Mobdy, Saeed Abdelwahab Saeed, Walid Ahmed Bichari, Omaira Ahmed Osman, Shereen Yousef Salah
{"title":"Exploring the relationship between serum vitamin D and atherosclerosis in hemodialysis patients: a cross-sectional study.","authors":"Ashraf Hassan Abd El Mobdy, Saeed Abdelwahab Saeed, Walid Ahmed Bichari, Omaira Ahmed Osman, Shereen Yousef Salah","doi":"10.3389/fneph.2026.1738155","DOIUrl":"10.3389/fneph.2026.1738155","url":null,"abstract":"<p><strong>Objective: </strong>To check if there is a link between good vitamin D levels in the blood and subclinical atherosclerosis in people on hemodialysis.</p><p><strong>Methods: </strong>Ninety end-stage renal disease patients undergoing regular hemodialysis were included in a cross-sectional study. Based on carotid intima-media thickness (CIMT), patients were grouped into Group A (n = 44) with normal CIMT and Group B (n = 46) with increased CIMT. Clinical assessments, laboratory parameters (serum vitamin D, lipid profiles, and inflammatory markers), and CIMT were measured using carotid ultrasound. The researcher compared students' t-tests with quantitative variables, while employing the Chi-square or Fisher's exact test with qualitative variables.</p><p><strong>Results: </strong>A positive correlation was observed between serum vitamin D and calcium (p = 0.010) and triglycerides (p = 0.025). Serum vitamin D showed a negative correlation with weight, serum alkaline phosphatase, and urea. No significant differences were found between the two groups in terms of demographic factors, BMI, hemodialysis duration, diabetes prevalence, or vitamin D supplementation. Group B exhibited elevated serum calcium levels (p = 0.008). Multivariate analysis found weight as an independent predictor of low vitamin D levels (p = 0.016).</p><p><strong>Conclusion: </strong>Serum calcium levels were significantly associated with CIMT; however, no correlation was seen between vitamin D levels and CIMT.</p><p><strong>Trial registration: </strong>registered at clinicaltrials.gov (ID: NCT07200804).</p>","PeriodicalId":73091,"journal":{"name":"Frontiers in nephrology","volume":"6 ","pages":"1738155"},"PeriodicalIF":2.9,"publicationDate":"2026-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13291148/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148335116","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}